Shattuck Labs, Inc. (STTK) Financials

STTK Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 159.6 million 14.9 million
2023-09-30 130.5 million 17.7 million
2023-06-30 155.3 million 16.8 million
2023-03-31 177.7 million 20.0 million

STTK Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -19.4 million 1.6 million
2023-09-30 -16.8 million 1.8 million
2023-06-30 -18.9 million 1.9 million
2023-03-31 -26.5 million 1.7 million

STTK Net Income

No data available :(

STTK Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 130.6 million - 4.2 million
2023-09-30 101.1 million - 4.4 million
2023-06-30 117.2 million - 4.6 million
2023-03-31 135.5 million - 4.0 million

STTK Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 43.0 million
2023-09-30 42.5 million
2023-06-30 42.5 million
2023-03-31 42.4 million

STTK Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 17000 15.2 million 4.4 million 981000
2023-09-30 19000 24.2 million 5.1 million -
2023-06-30 296000 18.2 million 4.7 million -
2023-03-31 75000 16.7 million 5.1 million -

STTK Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 714000 981000
2023-09-30 686000 1.0 million
2023-06-30 200000 1.1 million
2023-03-31 57000 1.1 million

STTK

Price: $11.22

52 week price:
1.33
11.22

Earnings Per Share: -2.05 USD

P/E Ratio: -4.29

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 37824

Market Capitalization: 443.4 million

Links: